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At one time, when antacids were the primary medical means of treating peptic
ulcer disease, the milk-alkali syndrome was not an uncommon cause ofhyper-
calcemia. The simultaneous occurence of hypercalcemia, alkalosis, and renal
failure, in conjunction with the appropriate history ofingestion fofantacids, was
suggestive ofthe syndrome. With the advent ofantisecretory therapy, however,
the milk-alkali syndrome has become an uncommon diagnosis. I report a case
of milk-alkali syndrome and review the hisory of this syndrome as reported in
the medical literature. Contemporary reports have focused on understanding the
pathophysiology of the syndrome. Recent series have indentified a shifting
demographic profile, as increasing numbers ofelderly women consume calcium
carbonate as an anti-osteoporosis measure.
INTRODUCTION
Milk-alkali syndrome (hypercalcemia and alkalosis associated with the ingestion of
large amounts of antacid containing calcium and absorbable alkali) was at one time a
somewhat regular cause of hypercalcemia, particularly in men with symptoms of peptic
ulcer disease. However, knowledge of its etiology, and more recently the development of
anti-secretory therapy for peptic ulcer disease, have caused this diagnosis to relegated to
the "rare" among those processes included in the differential diagnosis ofhypercalcemia.
I describe a case ofmilk-alkali syndrome caused by excess ingestion of calcium carbon-
ate, and review the literature, chronologically highlighting significant reports and studies
ofthis syndrome from the early twentieth century until the present. Some recent literature
suggests that the incidence ofmilk-alkali syndrome may be rising in new patient popula-
tions.
CASE REPORT
A 66 year old white male was brought by his friends to Jacobi Medical Center after
becoming lethargic and distressed in a social club. The patient, whose past medical histo-
ry included ethanol abuse, had been feeling ill for approximately three weeks. Over that
time, according to his wife, he had been nauseated, anorectic and constipated, and he had
some occasional vomiting. Additionally, the patient had been consuming large amounts of
laxatives, TumsTm and RolaidsTm daily. His diet had consisted mainly ofEnsureTm during
this period ofanorexia. During the week prior to admission, his symptoms worsened and
he became pale. On the day ofadmission, the patient went tojury duty in the morning, but
excused himself during the day because he felt ill. In the late afternoon, he attended a
social club (American Legion) where he had, by his report, two or three beers. Over the
course ofthe afternoon and evening, his friends noted that he became lethargic, distressed
and clutched his chest, and at their insistence, he agreed to come to the Emergency
Department.
a To whom all correspondence should be addressed: Anthony S. Fiorino, M.D., Ph.D., Department
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His past medical history included cataract surgery two years prior to admission, and
a hospitalization 18 years prior to admission for a questionable myocardial infarction;
details of this admission were vague and there was little evidence to suggest coronary
artery disease. Additionally, the patient had a history of ethanol abuse. His wife reported
that prior to his retirement 2 years ago, he would drink in the evenings at the social club,
and at home as well; she estimated his daily beer consumption at 10 cans. She stated that
his drinking did not interfere with his work, managerial in nature, but that his drinking had
increased since retirement and she denied that he had any episodes ofethanol withdraw-
al. The patient's ethanol consumption had decreased while he felt unwell over the weeks
prior to admission. He reported taking no medications other than the antacids previously
mentioned.
In the Emergency Department, he was afebrile, with a heart rate of 98 beats per
minute, blood pressure of 108/58 mm Hg, and a respiratory rate of 12 breaths perminute.
He was alert and fully oriented, and his physical exam revealed no abnormalities.
Table 1. Initial hematologic and blood chemistry studies.
Test (unit) Value
Hemoglobin (mg/dl)
MCV (mm3)
White-cell count (per ml)
Erythrocyte Sedimentation Rate (mm/hr)
Sodium (meq/l)
Potassium (meq/l)
Chloride (meq/l)
Carbon Dioxide (meq/l)
Urea Nitrogen (mg/dl)
Creatinine (mg/dl)
Glucose (mg/dl)
Calcium (mg/dl)
Magnesium (mg/dl)
Phosphate (mg/dl)
Urate (mg/dl)
Albumin (mg/dl)
Total Protein (mg/dl)
Arterial pH
PCO2 (mm Hg)
P02 (mm Hg)
Osmolality (mosm/kg)
Ethanol (mg/dl)
10.4
105.8
19,000, 87 % granulocytes
124
133
3.2
76
33
56
5.7
100
17.8
1.9
2.4
11.2
3.9
7.5
7.54
49
94
324
135
Amylase, Lipase, Lactate Dehydrogenase, Creatine Kinase, Alkaline
Phosphatase, and transaminase activities were within normal limits
Significant admission laboratory studies are summarized in Table 1; his urea nitrogen and
creatinine were normal at the time ofhis cataract surgery two years ago.
His chest X-ray showed a possible right upper lobe infiltrate, and his electrocardio-
gram showed ST-segment depressions in leadsV3 andV4. Because ofthe history ofchest-
clutching and the cardiogram findings, he was admitted to the Cardiac Care Unit. He was
hydrated and given thiamine, folate, phosphate, potassium and magnesium supplements.
Serial measurements ofserum creatine kinase were within normal limits. With hydration,
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his electrolytes and calcium normalized within several days, but his urea nitrogen
remained steady and his creatinine initially fell only slightly (Table 2). His N-terminus
parathyroid hormone was suppressed (under 9.5 pg/ml) on hospital days 2 and 5 (when
serum calcium was 13.8 and 9.6 mg/dl, respectively). Other significant laboratory data
included serum and urine electrophoreses thatrevealed no paraprotein, and no parathyroid
hormone-related peptide.
After the first week of admission, he became transiently hypocalcemic and hyperna-
tremic (Table 2), managed with cautious calcium supplementation and free water replace-
ment, respectively. He regained partial kidney function, as his creatinine eventually fell
into the range of 1.8 to 2.2 mg/dl (Table 2). Despite these improving laboratory studies,
his hospital course was complicated by a deteriorating mental status (CT scan ofthe head
and cerebrospinal fluid analysis were both normal), an upper gastrointestinal bleed, aspi-
ration pneumonia, sepsis with multi-organ failure, and disseminated intravascular coagu-
lation. Despite intravenous antibiotics, mechanical ventilation and aggressive attempts at
maintaining his blood pressure, the patient expired three weeks after admission. A request
for autopsy was declined.
Table 2. Significant blood chemical values during the first eleven days ofadmission.
Day [Na]* [K]* [Cl]* [HCO3I* BUNt Creatininet Cat Phosphatet
1 133 3.2 76 33 54 5.7 17.8 2.4
2 138 3.7 86 39 67 5.5 13.8
3 141 3.0 96 33 65 4.7 11.5
4 149 3.0 111 24 65 5.2 10.7 1.5
5 153 4.0 113 22 54 3.5 9.6 2.9
6 154 3.1 119 21 71 4.6 9.2 1.6
7 153 2.7 116 21 69 4.8 8.5 2.0
8 152 3.6 123 21 49 4.2 7.7 1.8
9 148 3.2 119 19 41 3.4 6.8 2.0
10 141 3.1 108 14 36 2.6 6.5 3.6
1 1 144 4.0 109 17 36 1.8 7.1 3.2
* Concentrations inmeq/l; t concentrations in mg/dl
DISCUSSION
In 1912, Sippy introduced a milk and antacid (calcium carbonate, sodium bicarbon-
ate, magnesium oxide, and bismuth subcarbonate) treatment for peptic ulcer disease [1].
Although "Sippy powders" proved to have some efficacy in relief of peptic ulcer symp-
toms, eleven years later, Hardt and Rivers described a syndrome of irritability, headache,
dizziness, nausea, vomiting, myalgia, weakness and apathy in 16 of 32 patients undergo-
ing the Sippy regimen, compared to 16 patients taking only milk [2]. These symptoms
were associated with elevated serum urea nitrogen and bicarbonate, proteinuria and
pyuria. Most of their patients recovered quickly after cessation of therapy, although one
died of"subacute nephritis." In 1934, Cope reported six new cases and found an elevation
of serum calcium, magnesium and phosphate in these patients, who had altered mental
status, vomiting, polyuria, myalgia and conjunctivitis [3]. The severity of alkalosis and
hypochloremia was observed to worsen with age in these patients, with hemorrhage, vom-
iting, gastric aspiration and pre-existing renal impairment factors [4]. Burnett and col-
leagues described a more severe syndrome, with prolonged, excessive intake ofmilk and
absorbable alkali, hypercalcemia, azotemia, proteinuria, alkalosis and calcinosis, without
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hypercalciuria or elevated serum alkaline phosphatase [5]. Calcifications were found in
the conjunctiva (band keratopathy), central nervous system, lymph nodes, vasculature and
subcutaneous tissue. Withholding milk and alkali resulted in the return of serum calcium
to normal values, hypophosphatemia and partial improvement in renal failure, although
four of the six reported patients died.
McMillan and Freeman studied the syndrome by randomly assigning 40 men (most
of whom had a history of peptic ulcer disease) to receive 6 ounces milk and either 3.6 g
calcium carbonate or 15 ml of aluminum hydroxide or aluminum magnesium hydroxide,
every two hours while awake (per day averages: 1.5 liters milk, 28 g calcium carbonate,
116 ml aluminum hydroxide or aluminum magnesium hydroxide) [6]. Serum levels ofcal-
cium, phosphate, creatinine and bicarbonate rose significantly in the calcium carbonate
group compared to the aluminum or magnesium hydroxide group, as did urinary calcium.
One patient developed symptoms of the syndrome, with marked elevations in serum cal-
cium, phosphate, urea nitrogen, creatinine and bicarbonate; his symptoms and laboratory
abnormalities subsided after discontinuation of milk and calcium carbonate.
Milk-alkali syndrome (hypercalcemia, alkalosis and renal failure due to ingestion of
calcium, absorbable alkali and milk) was initially thought to comprise three distinct enti-
ties: an acute syndrome, as described by Hardt and Rivers in 1923, the chronic, severe
"Burnett's syndrome," and the intermediate "Cope's syndrome." A history of milk and
alkali ingestion, nausea, vomiting, lethargy, mental status changes and myalgias, elevated
serum calcium, creatinine, and urea nitrogen, and normal to elevated phosphate and bicar-
bonate were shared features. The acute syndrome was thought to arise after short-term
treatments and to resolve rapidly after withdrawal of milk and alkali, the subacute syn-
drome after intermittent, long-term milk/alkali treatment with additional features of poly-
dipsia, polyuria, conjunctivitis and occasional band keratopathy, and the chronic syn-
drome after continuous long-term therapy, with additional features of pruritis, polydipsia,
polyuria, band keratopathy and soft tissue calcifications including nephrocalcinosis. In
chronic patients, symptoms might improve with renal function remaining at least partial-
ly impaired.
More recently, pathophysiology ofmilk-alkali syndrome was reviewed [7]. Although
high calcium intake lowers 1,25 dihydroxy-vitamin D levels, there is wide variability in
the fraction of calcium that is passively absorbed from the gastrointestinal tract in the
absence of 1,25 dihydroxy-vitamin D, and a subgroup ofindividuals will have a high frac-
tional absorption of calcium despite a large dietary calcium load and suppression of 1,25
dihydroxy-vitamin D. In the presence of any impairment in renal calcium excretion, these
individuals will become hypercalcemic. Additionally, alkalosis likely compromises renal
calcium excretion. However, alkalosis should not be expected from the relatively small
alkali load in calcium carbonate consumption, since massive loads of sodium bicarbonate
do not cause significant changes in systemic pH in normal individuals. However, several
factors limit bicarbonate excretion during calcium carbonate ingestion: increased calcium
causes increased sodium and free water excretion, which may cause volume depletion and
consequently, increased proximal tubule bicarbonate reabsorption; parathyroid hormone
suppression as well as direct tubular effects of calcium may also increase bicarbonate
reabsorption. Thus other factors leading to volume contraction (vomiting, gastric aspira-
tion, hemorrhage, thiazide diuretics), alkalosis (vomiting, gastric aspiration,
hypokalemia), or impaired calcium clearance (pre-existing renal disease, volume contrac-
tion, thiazide diuretics) act to predispose a patient to the development of the milk-alkali
syndrome.
The renal dysfunction of the milk-alkali syndrome results from multiple factors:
hypercalcemia can directly cause a decrease in glomerular filtration rate and creatinine
clearance, and dehydration contributes to renal impairment. Moreover, hypercalcemia and
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alkalosis, especially ifthere is hyperphosphatemia due to suppression ofparathyroid hor-
mone, can lead to nephrocalcinosis and significant, irreversible defects in renal function.
Understanding the pathophysiology ofmilk-alkali syndrome has made clear that there are
not three distinct entities, but rather a continuum of disease that is fully reversible in the
early stages but over time, with increasing soft tissue calcification, becomes irreversible
and is associated with renal failure and poor outcomes.
Abreo and coworkers examined hormonal parameters in a recent series [8]. Despite
heterogeneity of presentation, all five had been consuming large doses of calcium and
absorbable alkali, and they had remarkably similar admission laboratory values: on aver-
age, calcium 13.5 mg/dl, phosphate 1.5 mmol/l, bicarbonate 39 meq/l, pH 7.55 and crea-
tinine 7.6 mg/dl. Measurement of 1,25 dihydroxy-vitamin D in four patients revealed low
values in two and low-normal values in two. Although paradoxically elevated parathyroid
hormone levels in milk-alkali syndrome had been previously reported, Abreo and cowork-
ers emphasize the need for determination of the N-terminus parathyroid hormone frag-
ment in these patients, as the C-terminus fragment is dependent upon glomerular filtration
for removal: in their patients, C-terminus parathyroid hormone was elevated, as expected,
while in four of five patients, N-terminus parathyroid hormone was low or low-normal.
The patient with an elevated N-terminus parathyroid hormone was suspected to have sec-
ondary hyperparathyroidism as a result ofrenal failure, in addition to the milk-alkali syn-
drome.
As the use ofmassive doses ofcalcium carbonate for the treatment ofpeptic ulcer dis-
ease has faded, the demographics ofthe disease has shifted. By 1982, patients who devel-
oped the syndrome were consuming lower doses of calcium carbonate (5 to 10 g daily)
and had predisposing factors such as pyloric obstruction, vomiting, hemorrhage,
hypokalemia, hypertension, pre-existing renal disease and use of thiazide diuretics [7].
More recently, Kapsner and coworkers further shifted the demographics in their study of
cardiac transplant patients treated with long-term calcium carbonate to prevent corticos-
teroid-associated peptic ulcer disease and osteoporosis [9]. They reviewed data from 297
transplant recipients receiving between 3.2 to 12 g calcium carbonate per day for up to one
year, and reported that 65 had serum calcium levels over 10.7mg/dl. Ofthe hypercalcemic
patients, 31 were also alkalotic and 37 had evidence of renal impairment. The authors
noted that the incidence ofmilk alkali syndrome may increase given the popularity ofrec-
ommending calcium supplementation for the prevention and treatment ofosteoporosis. In
another study, Beall and Scofield recently reported three cases of milk-alkali syndrome,
and reviewed all patients admitted with hypercalcemia to the University of Oklahoma
Medical Center between January 1985, and December, 1993 [10]. They found seven of
100 patients who fit the criteria for milk-alkali syndrome on the basis of increased con-
sumption of calcium and absorbable alkali, hypercalcemia, metabolic alkalosis, and
absence of other cause for hypercalcemia. The laboratory profile of these patients was
similar to those ofAbreo et al. [8]: calcium 14.6 mg/dl, phosphate 2.9 mg/dl (four ofseven
subjects were hypophosphatemic and one of seven was hyperphosphatemic), bicarbonate
31 meq/l (four of seven subjects had bicarbonate levels of28-29 meq/l), and creatinine 2.1
mg/dl (three of seven had normal creatinine levels). Of the six patients in which it was
measured, parathyroid hormone was low in three and low-normal in three. After treatment
for hypercalcemia, one patient developed marked, symptomatic hypocalcemia with high
parathyroid hormone levels, and another developed asymptomatic hypocalcemia. The
authors attributed this to suppression of parathyroid hormone, for in the milk-alkali syn-
drome, unlike hyperparathyroidism or malignancy-related hypercalcemia, there is no
stimulus for calcium absorption from bone as the hypercalcemia is treated. They found
that recent reports of milk-alkali syndrome have neither been associated with hyperphos-
phatemia nor with ingestion of large quantities of milk (a source of dietary phosphate).
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These authors also noted that this syndrome may become more common as increasing
numbers of women are taking calcium carbonate for treatment or prevention of osteo-
porosis.
The case we have described is typical of the traditional presentation of milk-alkali
syndrome. The patient presented with a history ofingestion oflarge quantities ofcalcium
carbonate-containing antacids, and additionally had been vomiting, causing both volume
contraction and further alkalosis, increasing his risk. Serum chemistries revealed the triad
of hypercalcemia, alkalosis and renal failure. More common causes of hypercalcemia,
which must be excluded to confirm the diagnosis, were not found: there was no evidence
ofmultiple myeloma or other malignancy, and parathyroid hormone was suppressed, rul-
ing out primary hyperparathyroidism. After being hydrated the patient became hypocal-
cemic, a phenomenon described previously by Beall and Scofield [14]. This rebound
hypocalcemia is likely a consequence of suppression of the parathyroid, which cannot
respond immediately to the rapid lowering of serum calcium achieved by hydration in
these patients. This results in alag time before secretion ofparathyroid hormone and stim-
ulation of calcium resorption from bone. In order to avoid rebound hypocalcemia in
patients suffering from the milk-alkali syndrome, perhaps gentle hydration is preferable,
in contrast to the vigorous hydration required in hyperparathyroidism and malignancy-
related hypercalcemia. Additionally, cautious use ofcalcium supplementation when serum
calcium levels fall into the normal range may bejustified. Finally, a more physiological-
ly elegant solution would be to administer parathyroid hormone to these patients as serum
calcium levels begin to fall. Although the patient's hypercalcemia and other electrolyte
disturbances responded to hydration and supplementation with potassium and eventually
calcium, and despite his improving renal function, his condition deteriorated, related to
the development of an aspiration pneumonia then sepsis thought unrelated to the milk-
alkali syndrome.
This patient fit the picture ofone who has classically developed milk-alkali syndrome
in that he was a male, ingesting antacid for relief of dyspeptic symptoms. However, as
emphasized by the recent literature devoted to this subject [7-10], the demographics ofthe
syndrome are shifting as other patient populations take dietary calcium supplements, par-
ticularly as an anti-osteoporosis measure. This emphasizes the need for a careful medica-
tion history, including over-the-counter medications. For anyone presenting with hyper-
calcemia, a direct inquiry regarding the use of antacids or calcium supplements will, in
most cases, rule out milk-alkali syndrome; occasionally, there will be a history ofcalcium
carbonate ingestion, and this history may alter the evaluation of the patient.
As the risk of developing milk-alkali syndrome is hypothesized to be related in part
to vitamin-D independent intestinal calcium absorption, it is difficult to know which
patients are at risk. It is also unknown ifconcurrent use ofvitamin D or activated vitamin
D increases the likelihood of developing milk-alkali syndrome by stimulating intestinal
calcium absorption in the absence of an endogenous, physiologic stimulus. It is clear that
patients with renal insufficiency or volume contraction also have a higher risk, raising the
possibility that for these patients, a lower daily dose or an alternate-day dosing schedule
would reduce their risk. Monitoring serum calcium levels may be useful since calcium
levels are elevated prior to irreversible renal damage.
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